RISUG. The Single dose, Safe, Reversible Contraceptive Method for Men

RISUG. The Single dose, Safe, Reversible Contraceptive Method for Men

RISUG. The Single dose, Safe, Reversible Contraceptive Method for Men

Bye-bye Vasectomies (and if women can have it their way, bye-bye oral contraceptive pills too) !

This wonder drug, which has been developed at the Indian Institute of Technology in Kharagpur, India, promises to be a much safer, easier and reversible contraceptive method for men, and has garnered widespread global interest.

As opposed to a vasectomy, which involves cutting the vas deferens, the RISUG (Reversible Inhibition of Sperm Under Guidance), acts through the injection of a polymer gel into the vas deferens, which then coats the inside walls of the vas deferens and chemically incapacitates released sperm, rendering them incapable of fertilizing any eggs.

Currently under advanced trials in India, where some men have used it successfully for over 15 years, RISUG offers results which are similar to a traditional vasectomy but with added advantages of the process being simple, relatively pain free and easily reversible.

Men who wish to reverse the procedure and restore fertility at any point after choosing this contraceptive method, can do so easily with the polymer being able to get flushed out of the system with another injection.

Biggest Contraceptive Revolution since the Condom?

Professor Sujoy Guha, Inventor of RISUG

Professor Sujoy Guha, Inventor of RISUG

Developed by an Indian scientist called Sujoy Guha, the RISUG concept has been developed and refined for over 30 years.

Through the trials carried out by Guha’s team across hundreds of men, RISUG was found to be 100% effective, with no failures or serious adverse reactions reported by any of the subjects. The procedure now being in late Phase III clinical trials in India means that usage of this drug could be approved in India in as little as two years.

The RISUG drug is simple to administer and inexpensive to manufacture, offering the developing world a cost effective solution towards avoiding unwanted pregnancies.

For the west, this contraceptive method offers a safer option for women when compared with the risks associated with the long-term use of birth-control pills, while also allowing men the option of not having to deal with the hassle of condoms or a vasectomy.

According to Ronald Weiss, a leading Canadian vasectomy surgeon and a member of the World Health Organization, the RISUG “holds tremendous promise”

“If we can prove that RISUG is safe and effective and reversible, there is no reason why anybody would have a vasectomy,” he said in a statement.

And while the RISUG does not protect the user against the spread of STDs, the belief is that the styrene maleic acid may reduce pH to a level capable of destroying HIV in semen. The drug is currently being studied to test its effectiveness as an anti-HIV agent.

Pharmaceutical Companies not so Keen

With the RISUG being a single-dose inexpensive drug – some estimates say that the syringe could end up costing more than the material it injects – pharma companies until now have not been too keen towards being corporate partners in facilitating the development of this drug.

Oral contraceptive pills need to be used everyday often for a long period of time, and constitute a more lucrative business as opposed to the easily affordable, one-time-use RISUG.

However, recently a small American foundation called Parsemus has purchased the rights to begin RISUG (Vasagel) clinical trials in the U.S starting next year. Parsemus hopes to launch the product in the U.S market by 2015.

Richard Meryn
Richard Meryn, Associate Editor Industry Leaders Magazine (www.industryleadersmagazine.com)

Recent Posts

Porsche’s Taycan EV outsells ICE powered its 911 sports car

Porsche’s Taycan EV outsells ICE powered its 911 sports car

The Porsche Taycan EV has outsold the Porsche 911 sports car for the first time since it was introduced in 2019 by the German automaker.
11 hours ago
Tesla expected to make a killing in Bitcoin profits in next earning report

Tesla expected to make a killing in Bitcoin profits in next earning report

The price of Bitcoins has rallied to another high in October after hitting around $64,800 in April. This time it has hit over $58,000 on Oct. 14.
2 days ago
Tesla Cybertruck V/s Rivian’s R1T

Tesla Cybertruck V/s Rivian’s R1T

The Tesla Cyberturck left many disappointed with its alien space ship-like design; though both trucks are still under production, what matters most is what comes under the hood.
3 days ago
College sports is multibillion dollar industry in the US

College sports is multibillion dollar industry in the US

According to data analyzed by GOBankingRates, head football coaches, closely followed by basketball coaches, easily rack up seven-figure salaries in the US.
4 days ago
Top women influencers in finance and wealth management

Top women influencers in finance and wealth management

It is only in the last century or so that women have been publicly acknowledged for their roles as leaders in various fields. Here’s a list of women influencers by Industry Leade
5 days ago
Brian Goldner, who led Hasbro’s transformation into an entertainment giant, passes away at 58

Brian Goldner, who led Hasbro’s transformation into an entertainment giant, passes away at 58

Brian Goldner, the CEO and Chairman of toymaker Hasbro, has died at age 58, the company said Tuesday (Oct. 12).
7 days ago